Casopitant: all 28 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.CompletedNCT00601172Phase 3Results posted
- A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary InsomniaCompletedNCT00650871Phase 2
- The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in SubjectsCompletedNCT00511823Phase 1
- A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy AdultsCompletedNCT00460707Phase 1
- The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With CancerCompletedNCT00440128Phase 1
- A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy AdultsCompletedNCT00437229Phase 1
- A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic ChemotherapyCompletedNCT00431236Phase 3
- Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)CompletedNCT00413023Phase 2
- A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).CompletedNCT00405080Phase 1
- Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]CompletedNCT00404378Phase 1
- A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human VolunteersCompletedNCT00404274Phase 1
- Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And VomitingCompletedNCT00366834Phase 3
- Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic ImpairmentCompletedNCT00359177Phase 1
- Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal ImpairmentCompletedNCT00358813Phase 1
- An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional DyspepsiaCompletedNCT00358410Phase 2
- Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary InsomniaCompletedNCT00354809Phase 2
- Cyclophosphamide Drug Interaction Study In Cancer PatientsTerminatedNCT00334646Phase 1
- Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In WomenCompletedNCT00334152Phase 3
- Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury PatientsTerminatedNCT00332319Phase 2
- fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety DisorderCompletedNCT00332046Phase 1
- Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In WomenCompletedNCT00326248Phase 3
- A Study Of GW679769 Compared To Placebo In Women With Overactive BladderCompletedNCT00321477Phase 2
- Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary InsomniaCompletedNCT00280436Phase 2
- Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary InsomniaCompletedNCT00280423Phase 2
- Post-Operative Nausea And Vomiting Study In Female PatientsCompletedNCT00274690Phase 2
- Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based ChemotherapyCompletedNCT00169572Phase 2
- Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic ChemotherapyCompletedNCT00104403Phase 2
- Study Of GW679769 In Major Depressive DisorderCompletedNCT00102492Phase 2